These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 10728879)

  • 1. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
    Kimmel HL; Carroll FI; Kuhar MJ
    Neuropharmacology; 2000 Feb; 39(4):578-85. PubMed ID: 10728879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
    Fleckenstein AE; Pögün S; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 1996 Oct; 279(1):200-6. PubMed ID: 8858994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum.
    Kimmel HL; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2003 Jan; 304(1):15-21. PubMed ID: 12490570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitter transporters synthesis and degradation rates.
    Kimmel H; Vicentic A; Kuhar MJ
    Life Sci; 2001 Apr; 68(19-20):2181-5. PubMed ID: 11358326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RTI-76, an irreversible inhibitor of dopamine transporter binding, increases locomotor activity in the rat at high doses.
    Kimmel HL; Carroll FI; Kuhar MJ
    Brain Res; 2001 Apr; 897(1-2):157-63. PubMed ID: 11282369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines.
    Morón JA; Brockington A; Wise RA; Rocha BA; Hope BT
    J Neurosci; 2002 Jan; 22(2):389-95. PubMed ID: 11784783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferential increases in nucleus accumbens dopamine after systemic cocaine administration are caused by unique characteristics of dopamine neurotransmission.
    Wu Q; Reith ME; Kuhar MJ; Carroll FI; Garris PA
    J Neurosci; 2001 Aug; 21(16):6338-47. PubMed ID: 11487657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RTI-76, an isothiocyanate derivative of a phenyltropane cocaine analog, as a tool for irreversibly inactivating dopamine transporter function in vitro.
    Wang LC; Berfield JL; Kuhar MJ; Carroll FI; Reith ME
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Sep; 362(3):238-47. PubMed ID: 10997726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
    Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
    J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.
    Boja JW; Carroll FI; Vaughan RA; Kopajtic T; Kuhar MJ
    Synapse; 1998 Sep; 30(1):9-17. PubMed ID: 9704876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat.
    Kimmel HL; Joyce AR; Carroll FI; Kuhar MJ
    J Pharmacol Exp Ther; 2001 Jul; 298(1):129-40. PubMed ID: 11408534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.
    Kokoshka JM; Vaughan RA; Hanson GR; Fleckenstein AE
    Eur J Pharmacol; 1998 Nov; 361(2-3):269-75. PubMed ID: 9865517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-isoxazol-3-phenyltropane derivatives of cocaine: molecular and atypical system effects at the dopamine transporter.
    Hiranita T; Wilkinson DS; Hong WC; Zou MF; Kopajtic TA; Soto PL; Lupica CR; Newman AH; Katz JL
    J Pharmacol Exp Ther; 2014 May; 349(2):297-309. PubMed ID: 24518035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the biogenic amine transporters. VIII: identification of a novel partial inhibitor of dopamine uptake and dopamine transporter binding.
    Rothman RB; Dersch CM; Carroll FI; Ananthan S
    Synapse; 2002 Mar; 43(4):268-74. PubMed ID: 11835522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys.
    Letchworth SR; Nader MA; Smith HR; Friedman DP; Porrino LJ
    J Neurosci; 2001 Apr; 21(8):2799-807. PubMed ID: 11306632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry and pharmacology of the piperidine-based analogues of cocaine. Identification of potent DAT inhibitors lacking the tropane skeleton.
    Kozikowski AP; Araldi GL; Boja J; Meil WM; Johnson KM; Flippen-Anderson JL; George C; Saiah E
    J Med Chem; 1998 May; 41(11):1962-9. PubMed ID: 9599245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2'-Substitution of cocaine selectively enhances dopamine and norepinephrine transporter binding.
    Seale TW; Avor K; Singh S; Hall N; Chan HM; Basmadjian GP
    Neuroreport; 1997 Nov; 8(16):3571-5. PubMed ID: 9427328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of cocaine effect on dopamine clearance in the core and shell of the nucleus accumbens of dopamine transporter knock-out mice.
    Budygin EA; John CE; Mateo Y; Jones SR
    J Neurosci; 2002 May; 22(10):RC222. PubMed ID: 12006604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the biogenic amine transporters. VI. Characterization of a novel cocaine binding site, identified with [125I]RTI-55, in membranes prepared from whole rat brain minus caudate.
    Rothman RB; Silverthorn ML; Baumann MH; Goodman CB; Cadet JL; Matecka D; Rice KC; Carroll FI; Wang JB; Uhl GR
    J Pharmacol Exp Ther; 1995 Jul; 274(1):385-95. PubMed ID: 7616423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-activity relationship studies of 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives and their N-analogues: evaluation of O-and N-analogues and their binding to monoamine transporters.
    Dutta AK; Fei XS; Beardsley PM; Newman JL; Reith ME
    J Med Chem; 2001 Mar; 44(6):937-48. PubMed ID: 11300876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.